Alexi Archambault, PhD, MPH

Contributor

Alexi Archambault, PhD, MPH, is the associate director of pharmacoepidemiology at Regeneron.

Articles by Alexi Archambault, PhD, MPH

ASCO 2025: Dr. Alexi Archambault Discusses the First-Line Combination of Cemiplimab and Chemotherapy for NSCLC

Alexi Archambault, PhD, MPHASCO 2025 | June 30, 2025

Dr. Archambault discusses the safety and effectiveness of cemiplimab plus chemotherapy for first-line treatment of aNSCLC.